FDA NDC Directory · JSON-LD · Markdown

EMRELIS

NDC 0074-1055 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameTelisotuzumab Vedotin
Labeler / ManufacturerAbbVie Inc.
Marketing categoryBiologic License Application · App BLA761384
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTELISOTUZUMAB VEDOTIN (100 mg/mL)
Marketing started20250514
Package count1

External sources

Source: openFDA. Public-domain (CC0).